Fiche du document
27 janvier 2021
- doi: 10.53738/REVMED.2021.17.723.0196
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.723.0196
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33507660
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_66C893415E171
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Mots-clés
COVID-19; Female; Humans; Neurology; Neuromyelitis Optica/epidemiology; Pandemics; SARS-CoV-2Sujets proches
AdministrationCiter ce document
A. Anichini et al., « Neurologie [Recent Advances in Neurology] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.723.0196
Métriques
Partage / Export
Résumé
Significant developments were published in 2020 in the field of blood biomarkers in Alzheimer's disease. Several studies helped to define more accurately the management of status epilepticus and of epilepsy in women of childbearing age. The new Swiss guidelines for the pre-hospital management of acute stroke were issued, as are new targets for stroke prevention. Numerous advances concerning the management of NMO-SD (NeuroMyelitis Optica Spectrum Disorder) were published. Different neurological presentations linked to the COVID-19 pandemic were described (central and peripheral). Several studies confirmed the effectiveness of new migraine treatments (including anti-CGRP). New pharmacological therapies are available for Parkinson's disease.